Global Hit Streaming Series Reaches Top Spot on Netflix and Earns International Acclaim
LOS ANGELES, Sept. 18, 2024 /PRNewswire/ -- The groundbreaking Netflix series "3 Body Problem," produced in collaboration with The Three-Body Universe, has garnered six nominations at the 76th Primetime Emmy Awards, including the prestigious Outstanding Drama Series prize. This recognition highlights the series' extraordinary production and global success.
According to official Netflix data, "3 Body Problem" topped Netflix's viewership charts, amassing over 46.6 million views within seven weeks of its release in March. With its broad appeal, the series drew a substantial international audience and ranked in the top ten across 93 countries and territories.
"The Three-Body Problem" trilogy stands as the leading Chinese novel series on the global stage. Translated into 35 languages, the trilogy has surpassed 30 million copies in sales and received over ten major international literary awards. The English version alone has sold more than 2.56 million copies, with a renewal fee of $1.25 million, setting a new benchmark for the export of Chinese literary rights overseas.
The Three-Body Universe (TBU), the exclusive global rightsholder for content development and commercial operations of "The Three-Body Problem" trilogy, continues to lead the IP industry with its innovative and captivating storytelling. The company's diverse portfolio spans film and television, pan-entertainment, interactive, and immersive experiences, with plans to release one to two major projects every year.
In addition to "3 Body Problem," TBU is also widely recognized for producing the hit Mandarin-language TV series "Three-Body." Beloved by Chinese audiences, the show has been broadcast on over 11 international television networks and streaming platforms, with Peacock distributing it in the U.S. The series has reached viewers across Asia, the Americas, Europe, and Oceania. "Three-Body" is also available on Tencent Video's international platform, WeTV, further extending its reach to ASEAN countries, as well as Arabic-, Spanish-, and Portuguese-speaking regions.
"The Three-Body Problem" IP has also expanded into a diverse range of cultural products. Its graphic novels have been commissioned for publication in 11 languages. Other successful adaptations include animated series, variety shows, VR/AR experiences, and immersive live events.
At the 2024 Shanghai International Film Festival, The Three-Body Universe CEO, Jilong (Cedric) Zhao spoke about the highly anticipated film adaptation of "The Three-Body Problem," set to be directed by Zhang Yimou. "We will bring together China's top creative talents and production expertise, working with industry-leading partners around the world to bring this film to the international stage." A veteran of IP development and operations, Zhao also shared his vision for the IP market. "2024 has seen the sensational debut of "3 Body Problem," marking the first year for the internationalization of the Three-Body franchise. The series achieved groundbreaking success in North American, Japanese, and Middle Eastern markets, which also drove a surge in book sales and Three-Body-themed merchandise. This triumph demonstrates the vast potential and promising future for the Three-Body IP and other Chinese intellectual properties on the global landscape."
Building on its current success, The Three-Body Universe is gearing up to develop its first animated feature film and video game for the global market. Through collaborating with world-class talents and business partners, The Three-Body Universe seeks to create groundbreaking, premium content that resonates with both domestic and international audiences, further expanding the reach and impact of the Three-Body IP worldwide.
For more information, please contact:
Emma NG, PR Dept., TBU
emma.ng@3body.com
WhatsApp: +86 15611739029
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
"3 Body Problem" Nominated for Outstanding Drama Series at the 76th Primetime Emmy Awards
Amid rising agricultural complexity and the push for sustainability, genomics is at the forefront of innovation in breeding practices.
SINGAPORE, Sept. 19, 2024 /PRNewswire/ -- Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologiesâ„¢, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate the adoption of genomics in agricultural applications. By combining Biosearch Technologies' targeted genotyping-by-sequencing library preparation methodology (Amp-Seq) with Illumina's proven and highly scalable sequencing technology, the partnership aims to deliver innovative solutions to researchers and breeders in the Asia Pacific (excluding China) and Latin America region.
Illumina has a long history of driving advancements in genomics, providing the tools and technologies that have revolutionized many applications, including agriculture. Biosearch Technologies, part of LGC Group's Diagnostics and Genomics business, is a recognized leader in agricultural genomics, offering a comprehensive range of services and solutions to support plant and animal breeding programs.
"This partnership represents a significant milestone in our mission to empower agricultural researchers and breeders and provide them with the tools they need to improve crop yields and address global food security challenges," said Dr. Evgeny Glazov, Senior Market Development Manager at Illumina. "By leveraging Biosearch Technologies' expertise in sequencing-based genotyping and Illumina's industry-leading sequencing platforms, we can deliver more efficient, accurate, and cost-effective solutions to the agricultural genomics community."
"We are excited about the opportunities our strategic partnership with Illumina is bringing to agricultural biotechnology. The collaboration will make it easier for both LGC and Illumina customers to access the powerful combination of Biosearch Technologies' industrial scale targeted genotyping by sequencing technologies like Amp-Seq with both medium and high-capacity Illumina sequencing platforms." Joris Parmentier, Associate Portfolio Director from Biosearch Technologies said, "Together we are accelerating breeding programs by increasing the throughput and multiplexing capabilities up to tens of thousands of samples per day and enabling industry leading same-day-sequencing protocols driving an increased rate of genetic gain and a faster route to getting new traits to the market.
The partnership will focus on commercializing innovative genomics-based solutions for various agricultural research and breeding applications in crops and livestock sectors, including:
By combining their strengths, Illumina and Biosearch Technologies aim to make genomics more accessible and affordable for agricultural researchers and breeders worldwide, driving innovation and sustainable food production.
About LGC Biosearch Technologies
Biosearch Technologies is the comprehensive genomics portfolio from LGC, providing products and services for genomic analysis that support mission critical applications for global customers in agrigenomics. Our integrated tools and technologies enable our customers' achievements whether through extraction (sbeadexâ„¢), oligonucleotides and reagents (KASPâ„¢, BHQplusâ„¢ probes, BHQâ„¢ Probe Master Mix), and instrumentation (oKtopureâ„¢, SNPline, Nexarâ„¢, and IntelliQubeâ„¢). We also offer lab services for extraction, genotyping, targeted genotyping by sequencing (GBS), SSR conversion, Sanger sequencing, and NGS. To learn more, visit: www.biosearchtech.com
About Illumina
Illumina is helping sustain the planet by unlocking the power of the genome. In 2023, we celebrate 25 years of innovation, which has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit illumina.com and connect on X(Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture
